Designing Growth Strategies is in our DNA

Insomnia Drugs Market Size, Share & Industry Analysis, By Drug Class (Dual Orexin Receptor Antagonists (DORAs), Z-drugs/Non-Benzodiazepine Hypnotics, Benzodiazepine Hypnotics, Melatonin Pathway Agents, and Others), By Disease Indication (Primary Chronic Insomnia Disorder, Comorbid Psychiatric Insomnia, Comorbid Neurologic/Pain-Related Insomnia, & Others), By Age Group (Adults and Pediatric), By Type (Branded and Generic), By Route of Administration (Oral and Others), By Distribution Channel (Hospital pharmacies, Drug Stores & Retail Pharmacies, & Others), and Regional Forecast, 2026-2034

Last Updated :July 23, 2026 | Format:PDF | Report ID: 116040

 

Ask Queries

man icon
Mail icon
Mail icon
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 190